4D Molecular Therapeutics, Inc. (FDMT) Reports Material Event to SEC
Filing Details 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) filed a Form 8-K with the Securities and Exchange Commission on July 20, 2026, disclosing a material event. Market…
Read more
